Wasim Malik

Wasim Malik is an accomplished professional with significant experience in the fields of technology and life sciences. Currently, Wasim serves as a Board Member at Prudentia Sciences and holds the position of Managing Partner at Iaso Ventures, focusing on early-stage investments and new venture creation. Wasim is also the Director of Biomarker Research at Harvard Medical School and Massachusetts General Hospital, actively involved in leadership roles within the Clinical Trial Network & Institute. Additional roles include Senior Advisor at the Broad Institute of MIT and Harvard, Research Affiliate at the Massachusetts Institute of Technology, and Board Member positions at various organizations including the Epilepsy Foundation, Scaffold Therapeutics, and Altimate: The Precision Psychiatry Company. Wasim's educational background includes a Ph.D. in Electrical Engineering from the University of Oxford, a postdoctoral position in Computational Neuroscience at MIT, and executive education in Venture Capital and Private Equity from Harvard Business School, along with additional studies at Saïd Business School.